Skip to content
PodParley
The MattCorc Podcast podcast artwork

PODCAST · business

The MattCorc Podcast

by Life Sciences Rush Hour - Inve

A daily, 5-10 minute, podcast where we talk about risk and investing. Find out more at mattcorc.com or shoot me an email at [email protected]. I would love to hear any feedback, including topic suggestions and insurance questions. If you would like to join me on an episode, send me an email.

Publisher-supplied feed metadata · PodParley refreshed May 21, 2025 · Source feed

Subscribe · 0 Bookmark

Episodes

  1. Where does the market go from here? Will retail investors sell?

    We talk about the recent market turmoil and how that will impact investor actions. Will investors stick to their guns or succumb and sell if the market continues to sell off. A few comments on Medtronic’s settlement and how insurance could have been implemented to reduce the financial burden for...

  2. What’s the deal with GE?

    GE has seen its market cap decrease by over $200B since 2016 and it now trades at around $8. Is this the correct value or should it be higher or perhaps lower?

  3. We changed our name and Amazon announced their new locations!

    Why we changed our name to the MattCorc Podcast. Who is taking the most risk with the Amazon headquarters, Amazon or the local/state government? What is Waymo? The first autonomous ride hailing service is getting ready to launch in Arizona.

  4. A $500 Million Biotech IPO. Amarin Data

    Moderna plans the biggest biotech IPO ever and we learn more about Amarin’s clinical study. Was mineral oil the best choice of placebo? Lessons we can learn from Amarin about D&O insurance.

  5. Herd Mentality. Why D&O benchmarking is a sales ploy. What to use to make a more informed decision.

    I talk about how brokers use benchmarking to sell you more D&O insurance. Brokers take advantage of herd mentality so insurers buy more D&O than they need.

  6. Why cost should only be one consideration

    Cost and its importance are discussed. Minor differences in coverage can cause major headaches when you have a claim.

  7. S&P Companies not as negative; Gene Therapy manufacturing is stretched thin

    Happy national doughnut day! Fewer companies in the S&P are providing negative guidance. What does this mean? How CFOs are protecting their balance sheets in the event their manufacturing is disrupted.

  8. Lessons from Halloween when your kids have peanut allergies

    Why is Aimmune (AIMT) up today? Is it because Halloween reminded investors how many types of candy have peanuts in them? A lesson on how to make sure you aren’t missing significant coverage gaps in your insurance program. Hint: I learned it from checking my kids Halloween candy.

  9. Swimming and the Dow Jones

    How my first time swimming in a lap pool in years was a good metaphor for today’s market and some other interesting facts on the financial markets.

  10. President’s Drug Pricing Speech and New CA Sexual Harassment Law

    An overview of the President’s drug pricing proposal and what the new California sexual harassment law could mean for your insurance.

  11. M&A Activity - Will Market Forces Play a Role?

    With biotech stocks sinking, the XBI just hit a 52 week low, and interest rates rising will we see an urgency for acquisitions to be done?

  12. Episode 36 - Concept or Concrete?

    Quick post on why Insurance buying doesn’t need to be so abstract.

  13. Episode 35 - McDermott Will & Emery Dealmaking Symposium Recap

    A ton was learned at the MWE life science deal making symposium and here I share that with you.

  14. Episode 34 - DeviceTalks Recap

    A synopsis of DeviceTalks Boston. Pathways to acquisition, hurdles that you might face and how to derisk your company to make it more appealing to investors and acquiring companies.

  15. Episode 33 - Chinese Espionage and Cyber Coverage

    What can we learn from the alleged Chinese cyber espionage incident and how cyber insurance could respond.

  16. Episode 32 - Can the Biotech IPO Market Sustain Itself?

    I would love to hear whether people believe the pace of biotech IPOs will continue. Hear my thoughts and share yours at mattcorc.com.

  17. I’m Doing an IPO and My D&O Insurance is Expensive

    Why D&O Insurance is expensive for life science companies and how the stage your company is in impacts pricing.

  18. FDA Condemns Undamaged Product - Insurance Should Have Paid

    A client had a fire and $250,000 in product was destroyed. Undamaged condemned stock was valued at over $500,000 but there insurance did not cover it. Find out why that should never happen.

  19. Episode 29 - MD Bio-Tech Conference Recap

    A recap of the Maryland Bio-Tech Conference that I recently attended.

  20. Episode 28 - NJTC CFO Forum Recap

    A recap of the CFO Forum put on by the NJ Tech Council. The speaker was Jim Mastakas who was the CFO of Amneal when they merged with Impax Labs

  21. Episode 27 - Monday Market Update

    The impacts of Hurricane Florence on the property insurance market are discussed

  22. Common Question Friday #1

    Why does a pre-clinical company need insurance?

  23. Apple Watch, Transitioning From Digital Health to Med Device

    A quick synopsis of how insurance liability changes as a company enters the realm to an FDA regulated product.

  24. Hurricane Florence and Where to Look for Property Coverage

    Where to look for additional coverage in your proprty policy above and beyond replacing your building or contents. Things to be aware of that could reduce coverage.

  25. Abbvie Testosterone Settlement and Product Liability

    I discuss the Abbvie testosterone settlement and the role of product liability insurance could play. Hurricanes and property insurance.

  26. Episode 22 - Boston Biotech Week and RESI

    A recap of Boston Biotech Week and the RESI conference. How insurance can help you stand out with investors.

  27. Episode 21 - Patent Insurance...It’s a Real Thing

    An overview of patent insurance and what it can do.

  28. Episode 20 - Opioid Settlement and Product Liability

    A discussion on Product Liability insurance in relation to a possible opioid settlement. Wage & Hour lawsuits are on the rise but there is a solution.

  29. What happens when your supply chain is disrupted?

    In the wake of an API manufacturer being shut down in China I discuss using insurance to mitigate the cash flow disruption.

  30. Should Public Companies Only Report Earnings Semi-Annually?

    The possible impacts on moving from quarterly to semiannual reporting periods for public companies on the D&O insurance marketplace

  31. Episode 17 - Getting Your Product Approved

    Amicus and Alnylam both got FDA approval last week. Find out how that can change their risk profile.

  32. Cyber Insurance - Is Change Coming?

    I discuss the PGA Championship being cyber extorted, CA Consumer Privacy Act and the role insurance plays in both of these events.

  33. Apple, AIG, D&O Insurance and Patents

    We discuss Apple hitting the $1 trillion mark, AIG going the other way, government taking your patent and D&O insurance

  34. Episode 14 - Securities Class Action Filings and D&O Cover

    I talk about the prevalence of securities class action filings and how D&O can protect you. I also discuss how we should not choose limits solely by what our peers have in place.

  35. Episode 13 - Sarepta and Insuring Regulatory Risk

    I talk about what we can learn from Sarepta's clinical hold and how they could insure such an event for their commercial product.

  36. Episode 12

  37. Keryx Merger and Supply Chain issues

    Today we are reminded, due to the news that Keryx and Akebia are merging, of what happens when you have a supply chain issue.

  38. Insuring the Black Swan

    Aquinox disaster and what you can do to protect your company from Black Swans.

  39. Stryker Acquisition, CRISPR problems

    Recap of today’s big events. Stryker bidding on Boston Scientific. CRISPR might cause cancer.

  40. Liability for Digital Health Products

    I discuss liability when a digital health product works but something bad happens. Blurring the lines of medtech and digital health.

  41. Medtech Conference 2018

    A brief review of the 2018 Medtech conference in Minneapolis

  42. Episode 6 - IPO and D&O

    IPO market is healthy. Rockwell Medical and how D&O insurance could provide balance sheet protection

  43. Episode 5 - Keytruda, Rockwell Medical, Spoilage

    Keytruda does it again in the clinic and also changes to M&A landscape. What’s going on at Rockwell Medical? Is your product temperature sensitive?

  44. Episode 4 - FDA and Hemophilia

    Quick rundown on FDA related news, Hemophilia news and how right to try could impact the insurance market

  45. May 17, 2018

  46. May 15, 2018

  47. May 11, 2018

    Episode 1 - Drug Pricing and Ford

Type above to search every episode's transcript for a word or phrase. Matches are scoped to this podcast.

Searching…

We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.

No matches for "" in this podcast's transcripts.

Showing of matches

No topics indexed yet for this podcast.

Loading reviews...

ABOUT THIS SHOW

A daily, 5-10 minute, podcast where we talk about risk and investing. Find out more at mattcorc.com or shoot me an email at [email protected]. I would love to hear any feedback, including topic suggestions and insurance questions. If you would like to join me on an episode, send me an email.

HOSTED BY

Life Sciences Rush Hour - Inve

CATEGORIES

business

Frequently Asked Questions

How many episodes does The MattCorc Podcast have?

The MattCorc Podcast currently has 47 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.

What is The MattCorc Podcast about?

A daily, 5-10 minute, podcast where we talk about risk and investing. Find out more at mattcorc.com or shoot me an email at [email protected]. I would love to hear any feedback, including topic suggestions and insurance questions. If you would like to join me on an episode, send me an email.

How often does The MattCorc Podcast release new episodes?

The MattCorc Podcast has 47 episodes. Check the episode list to see recent publication dates and frequency.

Where can I listen to The MattCorc Podcast?

You can listen to The MattCorc Podcast on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.

Who hosts The MattCorc Podcast?

The MattCorc Podcast is created and hosted by Life Sciences Rush Hour - Inve.
URL copied to clipboard!